Literature DB >> 33196783

Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.

Zahin Amin-Chowdhury1, Felicity Aiano1, Anna Mensah1, Carmen L Sheppard2, David Litt2, Norman K Fry1,2, Nick Andrews3, Mary E Ramsay1,4, Shamez N Ladhani1,5.   

Abstract

BACKGROUND: Streptococcus pneumoniae coinfection with influenza results in synergistic lethality, but there are limited data on pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
METHODS: Public Health England conducts invasive pneumococcal disease (IPD) and SARS-CoV-2 surveillance in England. IPD trends during 2000/2001-2019/2020 epidemiological years were analyzed and cases during February-June 2020 linked with laboratory-confirmed SARS-CoV-2 infections. Multivariable logistic regression was used to assess risk factors for death.
RESULTS: IPD incidence in 2019/2020 (7.6/100 000; n = 3964) was 30% (IRR, .70; 95% CI, .18-2.67) lower compared with 2018/2019 (10.9/100 000; n = 5666), with large reductions observed across all age groups during March-June 2020. There were 160 886 SARS-CoV-2 and 1137 IPD cases during February-June 2020, including 40 IPD/coronavirus disease 2019 (COVID-19) co-infections (.025% [95% CI, .018-.034] of SARS-CoV-2 infections; 3.5% [2.5-4.8] of IPD cases), 21 with COVID-19 diagnosed 3-27 days after IPD, and 27 who developed COVID-19 ≥28 days after IPD. Case-fatality rates (CFRs) were 62.5 (25/40), 47.6% (10/21), and 33.3% (9/27), respectively (P < .001). In addition to an independent association with increasing age and serotype group, CFR was 7.8-fold (95% CI, 3.8-15.8) higher in those with IPD/COVID-19 coinfection and 3.9-fold (95% CI, 1.4-10.7) higher in patients who developed COVID-19 3-27 days after IPD compared with patients with IPD only.
CONCLUSIONS: Large declines in IPD were observed following COVID-19 lockdown. IPD/COVID-19 coinfections were rare but associated with high CFR, mainly in older adults. The rarity, age and serotype distribution of IPD/COVID-19 coinfections do not support wider extension of pneumococcal vaccination. © Crown copyright 2020.

Entities:  

Keywords:  bacterial coinfection; case fatality; nosocomial infection; pneumococcal disease; risk factor

Year:  2021        PMID： 33196783      PMCID： PMC7717180          DOI： 10.1093/cid/ciaa1728

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  38 in total

1.  TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Authors:  Federico Martinón-Torres; Adolfo García-Sastre; Andrew J Pollard; Carlos Martín; Albert Osterhaus; Shamez N Ladhani; Octavio Ramilo; Jose Gómez Rial; Antonio Salas; F Xavier Bosch; María Martinón-Torres; Michael J Mina; James Cherry
Journal:  Hum Vaccin Immunother       Date:  2021-11-11       Impact factor: 3.452

2.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Pui-Hing Chau; Albert Ka-Wing Au; Kelvin Hei-Yeung Chiu; Xin Li; Patrick Ip; Vivien Wai-Man Chuang; David Christopher Lung; Cindy Wing-Sze Tse; Rodney Allan Lee; Kitty Sau-Chun Fung; Wing-Kin To; Raymond Wai-Man Lai; Tak-Lun Que; Janice Yee-Chi Lo; Kwok-Yung Yuen
Journal:  Antibiotics (Basel)       Date:  2022-05-31

4.  COVID-19 containment measures and incidence of invasive bacterial disease.

Authors:  David R M Smith; Lulla Opatowski
Journal:  Lancet Digit Health       Date:  2021-06

5.  Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong.

Authors:  Jade L L Teng; Kenny M N Fok; Ken P K Lin; Elaine Chan; Yuanchao Ma; Susanna K P Lau; Patrick C Y Woo
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

6.  Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic.

Authors:  Nobuyuki Horita; Hideaki Kato; Keisuke Watanabe; Yu Hara; Nobuaki Kobayashi; Takeshi Kaneko
Journal:  Respirology       Date:  2021-11-21       Impact factor: 6.424

7.  Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa.

Authors:  Ben Morton; Kayla G Barnes; Jennifer Cornick; Kondwani C Jambo; Catherine Anscombe; Khuzwayo Jere; Prisca Matambo; Jonathan Mandolo; Raphael Kamng'ona; Comfort Brown; James Nyirenda; Tamara Phiri; Ndaziona P Banda; Charlotte Van Der Veer; Kwazizira S Mndolo; Kelvin Mponda; Jamie Rylance; Chimota Phiri; Jane Mallewa; Mulinda Nyirenda; Grace Katha; Paul Kambiya; James Jafali; Henry C Mwandumba; Stephen B Gordon
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

8.  In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles.

Authors:  B Morton; K G Barnes; C Anscombe; K Jere; R Kamng'ona; C Brown; J Nyirenda; T Phiri; N Banda; C Van Der Veer; K S Mndolo; K Mponda; J Rylance; C Phiri; J Mallewa; M Nyirenda; G Katha; P Kambiya; J Jafali; H C Mwandumba; S B Gordon; J Cornick; K C Jambo
Journal:  medRxiv       Date:  2021-02-20

9.  Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract.

Authors:  Joseph A Lewnard; Katia J Bruxvoort; Heidi Fischer; Vennis X Hong; Lindsay R Grant; Luis Jódar; Bradford D Gessner; Sara Y Tartof
Journal:  J Infect Dis       Date:  2022-05-16       Impact factor: 7.759

Review 10.  [Pneumococcal vaccination].

Authors:  Mathias W Pletz; Christina Bahrs
Journal:  Internist (Berl)       Date:  2021-07-12       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.